WHO H1N1 vaccine provided to developing countries

WHO H1N1 vaccine provided to developing countries

WHO has signed an agreement with Glaxo Smith Kline Pharmaceuticals, under which the last to donate about 50 million doses of influenza vaccine type (a) of the Organization by the end of this month.
The Organization has a list of 95 countries deserve to receive doses of the vaccine and can cover these doses 10% of the population of these States.

She said WHO Director-General, Margaret Chan, "We welcome this generous donation, which will protect the health of the poorest people in the world."

She added that "This is global solidarity with those who can not get this vaccine, and WHO will work on the arrival of these vaccines to those who need it."

The organization had warned last week that the world has yet to reach the spread of flu season is between January and February as it is expected the occurrence of further cases, the organization also stressed that, despite the side effects of the vaccine but the best tools available to combat the flu .

And even the first of this month have been reported 482,000 confirmed cases of avian type (a) in the world with the occurrence of 6000 deaths.

WHO advisors paid by H1N1 vaccine makers profiting on fear?

It's the kind of information that fuels conspiracy theorists everywhere... Danish journalists claim several World Health Organisation advisers are on the payroll of leading pharmaceutical companies that make swine flu vaccines. RT talks to Louise Volle, a journalist at the Danish Daily Information newspaper and a co-author of the report.